---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-140749"
form_type: "8-K"
ticker: "CERS"
cik: "0001020214"
company_name: "CERUS CORP"
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:15:52.687052+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cerus extends Fresenius supply agreement for INTERCEPT disposables through 2031

## Summary
- Second Amended and Restated Supply and Manufacturing Agreement signed May 2, 2022, term until Dec 31, 2031.
- Fresenius obligated to manufacture finished platelet and plasma disposable kits; Cerus obligated to purchase.
- Cerus may source from third parties for supply qualifications or local/regional manufacturing needs.
- Fresenius will expand production to three facilities following qualification and licensure.
- Pricing based on volume with annual adjustment tied to a price index; standard termination rights apply.

## SEC filing metadata
- accession: 0001193125-22-140749
- form_type: 8-K
- ticker: CERS
- cik: 0001020214
- company_name: CERUS CORP
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1020214/000119312522140749/0001193125-22-140749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1020214/000119312522140749/d306243d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-140749
- JSON: https://secwatch.observer/filing/0001193125-22-140749.json
- Plain text: https://secwatch.observer/filing/0001193125-22-140749.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.